PolarityTE Inc. (PTE) and Realm Therapeutics Plc (NASDAQ:RLM) Comparison side by side

Since PolarityTE Inc. (NASDAQ:PTE) and Realm Therapeutics Plc (NASDAQ:RLM) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affect the dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership of both companies.

Valuation and Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PolarityTE Inc. 5.50M 26.04 116.36M -4.25 0.00
Realm Therapeutics Plc N/A 51.72 13.63M -2.92 0.00

In table 1 we can see PolarityTE Inc. and Realm Therapeutics Plc’s gross revenue, earnings per share (EPS) and valuation.


Table 2 demonstrates the net margins, return on assets and return on equity of PolarityTE Inc. and Realm Therapeutics Plc.

Net Margins Return on Equity Return on Assets
PolarityTE Inc. -2,115.64% 0% 0%
Realm Therapeutics Plc 0.00% 0% 0%

Insider & Institutional Ownership

PolarityTE Inc. and Realm Therapeutics Plc has shares owned by institutional investors as follows: 49.7% and 46.35%. Insiders owned 31.2% of PolarityTE Inc. shares. Comparatively, insiders own roughly 31.1% of Realm Therapeutics Plc’s shares.


In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
PolarityTE Inc. -3.8% -5.92% -48.9% -39.6% -70% -39.96%
Realm Therapeutics Plc -1.98% -18.17% 46.67% 5.26% 0% 78.38%

For the past year PolarityTE Inc. had bearish trend while Realm Therapeutics Plc had bullish trend.


Realm Therapeutics Plc beats PolarityTE Inc. on 5 of the 7 factors.

PolarityTE, Inc. operates as a biotechnology and regenerative biomaterials company in the United States. The company focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Realm Therapeutics Plc, a biopharmaceutical company, focuses on developing therapies for the treatment of immune-mediated diseases in adults and children. Its product pipeline includes PRO22, a topical gel, which is conducting initial Phase II clinical studies for the treatment of atopic dermatitis. The company was formerly known as PuriCore plc and changed its name to Realm Therapeutics Plc in December 2016. Realm Therapeutics Plc is based in London, the United Kingdom.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.